Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFD-03 Lotion in Acne Vulgaris
2015-004765-90Phase 2Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Nov 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acne vulgaris comparing DFD-03 (tazarotene) lotion with Vehicle lotion (2 arms). Primary endpoint: Absolute change in inflammatory lesion counts at Week 12. Started Nov 2015; status: completed.
02
Drugs
tazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2015-004765-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004765-90.